About Alebund
Alebund is a company based in Shanghai (China) founded in 2018 by Gavin Xia and Jin Tian.. Alebund has raised $114.5 million across 3 funding rounds from investors including Verition Fund Management, 3H Health Investment and Morningside China. Alebund operates in a competitive market with competitors including Calliditas Therapeutics, Unicycive, Akebia Therapeutics, Aurinia Pharmaceuticals and Renalys, among others.
- Headquarter Shanghai, China
- Founders Gavin Xia, Jin Tian
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$114.5 M (USD)
in 3 rounds
-
Latest Funding Round
$54.5 M (USD), Series B
Sep 13, 2021
-
Investors
Verition Fund Management
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Alebund
Alebund has successfully raised a total of $114.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $54.5 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $54.5M
- First Round First Round
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series B - Alebund | Valuation | 3H Health Investment , Morningside | |
| May, 2021 | Amount | Series B - Alebund | Valuation | Quan Capital | |
| Jun, 2020 | Amount | Series A - Alebund | Valuation | Huagai Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alebund
Alebund has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Verition Fund Management, 3H Health Investment and Morningside China. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in health innovation and therapies is facilitated.
|
Founded Year | Domain | Location | |
|
Mid-market companies are targeted for investment by Loayal Valley Capital.
|
Founded Year | Domain | Location | |
|
BioVenture is focused on early and growth-stage healthcare investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alebund
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alebund
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alebund Comparisons
Competitors of Alebund
Alebund operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Calliditas Therapeutics, Unicycive, Akebia Therapeutics, Aurinia Pharmaceuticals and Renalys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of small molecule based drug for inflammatory kidney disease
|
|
| domain | founded_year | HQ Location |
Small molecule therapies for kidney diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics.
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by Aurinia Pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Therapeutics for renal diseases are developed and launched by Renalys.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alebund
Frequently Asked Questions about Alebund
When was Alebund founded?
Alebund was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Alebund located?
Alebund is headquartered in Shanghai, China.
Who is the current CEO of Alebund?
Gavin Xia is the current CEO of Alebund. They have also founded this company.
Is Alebund a funded company?
Alebund is a funded company, having raised a total of $114.5M across 3 funding rounds to date.
What does Alebund do?
Alebund was established in 2018 in Shanghai, China, within the biotechnology sector. Focus is placed on developing therapeutics for kidney-related conditions. Operations center on advancing lead candidates such as AP-301 for hyperphosphatemia treatment, AP-303 for diabetic kidney disease, and AP-304 for autosomal dominant polycystic kidney disease. Further pipeline includes AP-302 and AP-305, an antibody targeting the complement lectin pathway for IgA nephropathy.
Who are the top competitors of Alebund?
Alebund's top competitors include Calliditas Therapeutics, Akebia Therapeutics and Gennova.
Who are Alebund's investors?
Alebund has 14 investors. Key investors include Verition Fund Management, 3H Health Investment, Morningside China, Loayal Valley Capital, and BioVenture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.